Related Experiment Video
Updated: Mar 29, 2026

09:35
Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
Published on: May 10, 2017
19.8K
Evidence-based treatments for cluster headache
Rubesh Gooriah1, Alina Buture1, Fayyaz Ahmed1
1Department of Neurology, Hull Royal Infirmary, Kingston upon Hull, UK.
Therapeutics and Clinical Risk Management
|December 5, 2015
Summary
Cluster headache (CH) treatments include rapid-acting oxygen or sumatriptan for acute attacks and verapamil for prevention. For chronic, refractory cases, hypothalamic deep brain stimulation shows promise.
Area of Science:
- Neurology
- Pain Medicine
Background:
- Cluster headache (CH) is an extremely painful neurological disorder.
- Acute attacks require rapid-acting treatments due to their severity and brevity.
- Preventive strategies are necessary for frequent or chronic cases.
Purpose of the Study:
- To review the pathogenesis of cluster headache.
- To evaluate the evidence supporting current acute and preventive treatment options for CH.
- To discuss emerging surgical interventions for refractory CH.
Main Methods:
- Review of existing literature on cluster headache treatment.
- Analysis of clinical evidence for acute therapies like oxygen inhalation and subcutaneous sumatriptan.
- Evaluation of preventive medications, particularly verapamil.
- Assessment of surgical options, including hypothalamic deep brain stimulation.
Main Results:
- Oxygen inhalation and subcutaneous sumatriptan are effective acute treatments for CH.
- Verapamil is the most effective preventive medication, though evidence is limited for many agents.
- Current treatments can be ineffective for chronic or refractory CH.
- Hypothalamic deep brain stimulation is a promising surgical option for severe, refractory cases.
Conclusions:
- Effective acute and preventive treatments exist for cluster headache, but evidence quality varies.
- Management of chronic refractory cluster headache may require advanced interventions like deep brain stimulation.
- Further research is needed to strengthen the evidence base for CH therapies.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Management of Insomnia
778
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
778

